MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $120,684,000 | +423.9% | 2,001,400 | +299.5% | 1.26% | +420.2% |
| Q1 2016 | $23,036,000 | +192.4% | 501,000 | +207.4% | 0.24% | +240.8% |
| Q4 2015 | $7,879,000 | -95.1% | 163,000 | -88.5% | 0.07% | -94.0% |
| Q2 2015 | $161,410,000 | -46.8% | 1,413,400 | -39.8% | 1.18% | -54.3% |
| Q1 2015 | $303,173,000 | +34.1% | 2,348,900 | +3.5% | 2.59% | +19.8% |
| Q4 2014 | $226,005,000 | +0.6% | 2,268,900 | -0.2% | 2.16% | -8.0% |
| Q3 2014 | $224,732,000 | +19.2% | 2,273,000 | -7.1% | 2.35% | +6.0% |
| Q2 2014 | $188,584,000 | +7.5% | 2,446,600 | -10.2% | 2.21% | +2.7% |
| Q1 2014 | $175,350,000 | -12.0% | 2,724,100 | -12.8% | 2.16% | -26.4% |
| Q4 2013 | $199,342,000 | +42.5% | 3,123,500 | +33.8% | 2.93% | +17.3% |
| Q3 2013 | $139,930,000 | +93.2% | 2,334,500 | +58.6% | 2.50% | +62.7% |
| Q2 2013 | $72,427,000 | – | 1,472,100 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,198,919 | $283,814,000 | 82.63% |
| BB BIOTECH AG | 1,274,706 | $164,526,000 | 4.90% |
| Selkirk Management LLC | 64,300 | $8,299,000 | 4.61% |
| Opus Point Partners Management, LLC | 30,747 | $3,969,000 | 3.33% |
| Arlington Capital Management, Inc. | 28,845 | $3,723,000 | 2.67% |
| Orbimed Advisors | 2,348,900 | $303,173,000 | 2.59% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 70,900 | $9,151,000 | 2.44% |
| HealthCor Management, L.P. | 375,000 | $48,401,000 | 2.31% |
| BENDER ROBERT & ASSOCIATES | 27,084 | $3,496,000 | 2.04% |
| Eventide Asset Management | 208,200 | $26,872,000 | 2.02% |